LAG3 and neoplasm: Third, the expression of other immune molecules should be detected together with the LAG-3 and PD-L1 to better understand the mechanism of TACE therapy affecting tumor immunity, so as to provide theoretical basis for the combination of TACE and immunotherapy in HCC patients.